Evolent Health shows strong revenue growth (47% YoY) and a recent earnings recovery, but near-zero margins, a 1.7 quality score, a 50% drawdown and only 4.2% upside to the analyst target leave a poor reward-to-risk of 0.28.
Thesis pillars
- Weak Profitability Quality↑Improving
- Revenue Rebound→Stable
- Earnings Turnaround Streak↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Oct 24, 2026, based on the 10-K filed Feb 25, 2026
Evolent Health, Inc (EVH) Stock Analysis
Range Bound setup · Inst Constrain edge
Healthcare · Health Information Services
Sell if holding. Engine safety override at $4.33: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: High short interest: 11%; Below-average business quality.
Evolent Health provides specialty care management and administrative services to health plans and other risk-bearing payers, concentrating on oncology, cardiology, and musculoskeletal conditions through its New Century Health platform and the Identifi value-based care... Read more
Sell if holding. Engine safety override at $4.33: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: High short interest: 11%; Below-average business quality. Chart setup: RSI 58 mid-range, Bollinger mid-band. Score 5.7/10, moderate confidence.
Passes 5/8 gates (clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio and earnings proximity 6d<=7d. Suitability: speculative.
Recent developments
updated 2026-10-29Recent Developments — Evolent Health, Inc
Latest news
- NEWS Evolent Health Introduces 'Sunlight' Solution for Independent Practices — fiscal.ai Oct 20, 2026 positive
- NEWS JP Morgan Maintains Overweight on Evolent Health, Raises Price Target to $6 — benzinga Aug 18, 2026 positive
- NEWS TD Cowen Maintains Buy on Evolent Health, Raises Price Target to $6 — benzinga Aug 17, 2026 neutral
- NEWS Tiger Global Management Increases Stake In Evolent Health Inc By 99% To 11,063,912 Shares — benzinga Aug 14, 2026
- NEWS Truist Securities Maintains Hold on Evolent Health, Lowers Price Target to $6 — benzinga Aug 12, 2026 neutral
Generated 2026-10-29T11:14:32Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomerMolina Healthcare26%10-K Item 1A: 'Our four largest partners in terms of revenue, Molina Healthcare, Inc. ("Molina"), Cook County Health and Hospitals System, Florida Blue and Centene Corporation comprised 25.7%, 16.4%, 14.2% and 12.2%, respectively, of our revenue'
- LOWCustomerCook County Health and Hospitals System16%10-K Item 1A: 'Our four largest partners in terms of revenue, Molina Healthcare, Inc. ("Molina"), Cook County Health and Hospitals System, Florida Blue and Centene Corporation comprised 25.7%, 16.4%, 14.2% and 12.2%, respectively, of our revenue'
- LOWCustomerFlorida Blue14%10-K Item 1A: 'Our four largest partners in terms of revenue, Molina Healthcare, Inc. ("Molina"), Cook County Health and Hospitals System, Florida Blue and Centene Corporation comprised 25.7%, 16.4%, 14.2% and 12.2%, respectively, of our revenue'
- LOWCustomerCentene Corporation12%10-K Item 1A: 'Our four largest partners in terms of revenue, Molina Healthcare, Inc. ("Molina"), Cook County Health and Hospitals System, Florida Blue and Centene Corporation comprised 25.7%, 16.4%, 14.2% and 12.2%, respectively, of our revenue'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Unprofitable operations — net margin -24.1%. Quality floor flags this regardless of sector context.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $4.33: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.7/10. Specifically: High short interest: 11%; Below-average business quality. Chart setup: RSI 58 mid-range, Bollinger mid-band. Prior stop was $4.03. Score 5.7/10, moderate confidence.
Analyst target: $5.00 (+15.5% upside). Prior stop was $4.03. Stop-loss: $4.03.
Quality below floor (1.7 < 4.0).
Evolent Health, Inc trades at a P/E of N/A (forward 10.7). TrendMatrix value score: 7.3/10. Verdict: Sell.
18 analysts cover EVH with a consensus score of 4.0/5. Average price target: $6.
What does Evolent Health, Inc do?Evolent Health provides specialty care management and administrative services to health plans and other risk-bearing...
Evolent Health provides specialty care management and administrative services to health plans and other risk-bearing payers, concentrating on oncology, cardiology, and musculoskeletal conditions through its New Century Health platform and the Identifi value-based care technology. The company is paid largely on a per-member-per-month basis, including capitated Performance Suite arrangements where it assumes medical cost risk. Its four largest partners — Molina Healthcare, Cook County Health and Hospitals System, Florida Blue, and Centene Corporation — comprised 25.7%, 16.4%, 14.2%, and 12.2%, r